Renal amyloidosis

British Journal of Hospital Medicine

Volumn 71, Issue 2, 2010, Pages 83-86

  Ladimaiin, Helen J ^a   Gillmore, Julian D ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956066571     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2010.71.2.46485     Document Type: Conference Paper

References (20)

1. Bergesio F, Ciciani AM, Santostefano M et al (2007) Renal involvement in systemic amyloidosis-an Italian collaborative study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant.22: 1608-18.
2. Bergesio F, Ciciani AM, Manganaro M et al (2007) Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant 23: 941-51.
3. Bollee G, Guery B, Joly D et al (2008) Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol 3: 375-81.
4. Gertz MA, Kyle RA, O'Fallon WM (1992) Dialysis support of patients with primary systemic amyloidosis. A study of- 211 patients. Arch Intern Med 152: 2245-50.
5. Gillmore JD, Booth DR, Rela M et al (2000) Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen a-chain variant in an English family. Q J Med 93: 269-75.
6. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001a) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of scrum amyloid A protein. Lancet 358: 24-9.
7. Gillmore JD, Stangou AJ, Tennent GA et al (2001b) Clinical and biochemical outcome of hepatorenal transplantation (or hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation 71: 986-92.
8. Gillmore JD, Stangou AJ, Lachmann HJ et al (2006) Organ transplantation in hereditary apolipoprotein AI amyloidosis. Am J Transpl 6: 2342-7.
9. Gillmore JD, Lachmann HJ, Rowczenio D et al (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. J Am Soc Nephrol 20: 444-51.
10. Haas M (1997) A reevaluation of routine electron microscopy in the examination of native renal biopsies. J Am Soc Nephrol 8: 70-6.
11. Hartmann A, Holdaas H, Fauchald P et al (1992) Fifteen years' experience with renal transplantation in systemic amyloidosis. Transpl Int 5: 15-18.
12. Lachmann HJ, Booth DR, Booth SE et al (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346: 1786-91.
13. Lachmann HJ, Gallimore R, Gillmore JD et al (2003) Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 122: 78-84.
14. Lachmann HJ, Goodman HJ, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356: 2361-71.
15. Luke RG, Allison ME, Davidson JF, Duguid WP (1969) Hyperkalemia and renal tubular acidosis due to renal amyloidosis. Ann Intern Med 70: 1211-17.
16. Martinez-Vea A, Garcia G, Carreras M, Revert L, Oliver JA (1990) End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Am J Nephrol 10: 283-9.
17. Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Lallan M (2000) Bleeding symptoms and coagulation abnormalities in 337 patients with AL amyloidosis. Br J Haematol 110:454-60.
18. Nishi S, Alchi B, Imai N, Gejyo F (2008) New advances in renal amyloidosis. Clin Exp Nephrol 12: 93-101.
19. Pepys MB (2006) Amyloidosis. Annu Rev Med 51: 223-41.
20. Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109: 1971-4.